Derek Saul, a Forbes breaking news reporter, joins 'Forbes Talks' to discuss the impact weight loss drugs like Ozempic and Wegovy could have on fitness stocks.

Stay Connected

Forbes newsletters: https://newsletters.editorial.forbes.com

Forbes on Facebook: http://fb.com/forbes

Forbes Video on Twitter: http://www.twitter.com/forbes

Forbes Video on Instagram: http://instagram.com/forbes

More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

D. A. N. MARSHALL

The AI-powered Podcast Player